Exciting 2026 ACC/AHA Dyslipidemia Guideline Updates for Nutrition & Exercise Management of Cholesterol disorders

The 2026 ACC/AHA report on the management of dyslipidemia has finally been published with updated guidance for the care and support of those with dyslipidemia, including high low-density lipoprotein cholesterol (LDL-C), hypertriglyceridemia, and elevated lipoprotein(a) [1]. The guidelines replace the “2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol”, which has been a staple for dyslipidemia recommendations for the past several years [2]. The new article places a stronger emphasis on nutrition and lifestyle as the foundation of lipid management than in previous guidelines. In this blog post, we review the most important nutrition and physical activity updates, and what they mean for real-life heart health.

Dietary Patterns Over Diet Trends or Single Nutrients

The new 2026 guidelines reinforce the notion Registered Dietitian Nutritionists have been pushing for years: dietary patterns drive the greatest improvements in LDL-C and overall cardiometabolic health [1]. While online personalities show off simple dietary supplements, flashy health powders, and rigid diet plans, the research shows that a few evidence-based dietary patterns provide far greater heart health benefits in improving lipid and triglyceride (TG) levels and reducing cardiovascular disease risk. Several dietary patterns were highlighted as showing strong evidence for dyslipidemia support, these include:

• Mediterranean Dietary Pattern

  • Emphasizes vegetables, fruits, whole grains, beans/legumes, nuts, olive oil, and seafood intake across the day and week.

• Dietary Approach to Stop Hypertension (DASH) Dietary Pattern

  • Focuses on vegetables, fruits, whole grains, low-fat dairy, and lean proteins with an emphasis on reduced/low sodium foods and cooking methods.

• Plant-Forward Dietary Patterns

  • Prioritizes regular consumption and use of plant proteins, intact fiber, and unsaturated fatty acids through plant oils and seafood.

While these dietary patterns are not new to the 2026 guidelines, their research findings continue to shine a light on the consistent evidence behind them on lipid level improvement. The new guidelines underscore that long-term adherence and consistency in these dietary patterns over infrequent adherence or intermittent diet trends drive true cardiometabolic risk reduction [1].

Key nutrients were highlighted within the article pointing towards clearer dietary targets for providers and patients to encourage and monitor. These include viscous/soluble fiber, unsaturated fatty acids, saturated fat, added sugars, refined grains, and omega-3 (EPA/DHA) consumption [1]. The report continues the recommendation of aiming transition and reduction of saturated fats towards unsaturated fatty acids, minimization and/or elimination of trans fats, and limiting cholesterol to <200 mg/day for those with dyslipidemia only [1].

As far as dietary supplements go, the ACC/AHA 2026 guidelines indicate that for individuals with dyslipidemia, the use of supplements to support lowering LDL-C or triglycerides (TG) is not recommended based on ongoing limited and inconsistent data and/or limited benefits in the reduction of lipid levels and ASCVD risk [1]. This is another strong guideline update that conveys the impact of whole foods and sufficient dietarty intake over unregulated dietary supplements in supporting long-term heart health and vital lab improvements.

Physical Activity as Therapy, Not a Suggestion

The 2026 ACC/AHA guidelines continues to strengthen the role of physical activity as the cornerstone of a healthy lifestyle and a primary adjunct lipid-lowering therapy to medications, rather than just an ongoing general health recommendation [1]. They note that several exercise modalities have shown favorable health effects on blood lipids such as higher high-density lipoprotein cholesterol (HDL-C), lower TG, and lower LDL-C [1]. They encourage clinicians to assess physical activity as a “vital sign” through reliable physical activity assessment tools (such as the PAR-Q) while encouraging personal preference in engagement [1].

The guidelines remain consistent with other medical organization’s recommendations for 150 minutes (or greater) of moderate-intensity or 75 - 150 minutes of vigorous intensity aerobic activity across the week, supplemented with at least two days of resistance exercise [1]. While the paper recommends clinicians and patients should be encouraged to aim for guideline-directed targets for physical activity, they highlight that any physical activity is likely to be beneficial in sedentary individuals to reduce cardiometabolic risk [1].

Weight Loss for Cardiometabolic Gains

While dietary strategies are a critical component of lifestyle management, weight loss is a major compliment in reduction of lipid levels and cardiovascular disease risk [1]. Through both nutrition and exercise interventions, weight loss of 5-10% current body weight has shown beneficial outcomes in lowering TG levels by 20-30%, or 4 mg/dL for every 1 kg lost, while improving insulin sensitivity [1]. They recommend all individuals with dyslipidemia and overweight or obesity to receive tailored nutrition and lifestyle counseling with a plan for sustainability for the long-term and not just until lipid levels improve [1]. Of their considerations for support, they point towards referral to a Registered Dietitian Nutritionist for these lifestyle counseling interventions to support meaningful and sustainable weight loss [1].

One interesting note within the guidelines is that research identified a potential physiological or secondary causes of hypercholesterolemia due to LDL-C can arise from rapid weight loss, and therefore encourage gradual, sustainable weight loss as a way to mitigate risk of disease development [1].

Medications are Enhanced Through Lifestyle Prescriptions and Dietitian Referrals

One major theme of the new 2026 ACC/AHA guidelines is the recommendation of adjunct therapy interventions through lifestyle prescriptions and Registered Dietitian Nutritionist referrals. While the guidelines thoroughly explore current and new pharmacotherapy interventions for management of cholesterol disorders, they routinely point to the essential nature of lifestyle prescription, including nutrition and exercise, as a cotherapy plan [1].

Throughout the report, lifestyle therapy was noted to enhance medication effectiveness, reduce need for lipid-lowering medication dose escalation, improve overall cardiometabolic health parameters, and support long-term CVD risk reduction [1].

Conclusion

Recent updated dyslipidemia guidance from the 2026 ACC/AHA report points towards the power and need for heart-healthy dietary patterns, sufficient physical activity, gradual and meaningful weight loss, and adjunct pharmacological therapy. Recommended dietary patterns focus around a balanced, high‑fiber, low‑saturated‑fat, minimally processed pattern with further tailoring of dietary limits per clinical guidance based on dyslipidemia phenotype. Ongoing recommendations for regular clinical evaluation and assessment with updated clinical criteria will support accurate disease identification and appropriate specialist referrals, including to Registered Dietitian Nutritionists for medical nutrition therapy [1].

References

1. Blumenthal RS, Morris PB, Gaudino M, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026;153(17):e1154-1276. doi:10.1016/CIR.0000000000001423

2. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082-e1143. doi:10.1161/CIR.0000000000000625